1. |
- Artiaco, Claudia, et al.
(author)
-
Spatiotemporal heterogeneity of entanglement in many-body localized systems
- 2022
-
In: Physical Review B. - : American Physical Society (APS). - 2469-9950 .- 2469-9969. ; 105:18
-
Journal article (peer-reviewed)abstract
- We propose a spatiotemporal characterization of the entanglement dynamics in many-body localized (MBL) systems, which exhibits a striking resemblance to dynamical heterogeneity in classical glasses. Specifically, we find that the relaxation times of local entanglement, as measured by the concurrence, are spatially correlated yielding a dynamical length scale for quantum entanglement. As a consequence of this spatiotemporal analysis, we observe that the considered MBL system is made up of dynamically correlated clusters with a size set by this entanglement length scale. The system decomposes into compartments of different activity such as active regions with fast quantum entanglement dynamics and inactive regions where the dynamics is slow. We further find that the relaxation times of the on-site concurrence become broadly distributed and more spatially correlated, as disorder increases or the energy of the initial state decreases. Through this spatiotemporal characterization of entanglement, our work unravels a previously unrecognized connection between the behavior of classical glasses and the genuine quantum dynamics of MBL systems.
|
|
2. |
- Toft Sörensen, Andreas, et al.
(author)
-
NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning.
- 2008
-
In: Hippocampus. - : Wiley. - 1050-9631 .- 1098-1063. ; 18:6, s. 564-574
-
Journal article (peer-reviewed)abstract
- Recombinant adeno-associated viral (rAAV) vector-induced neuropeptide Y (NPY) overexpression in the hippocampus exerts powerful antiepileptic and antiepileptogenic effects in rats. Such gene therapy approach could be a valuable alternative for developing new antiepileptic treatment strategies. Future clinical progress, however, requires more detailed evaluation of possible side effects of this treatment. Until now it has been unknown whether rAAV vector-based NPY overexpression in the hippocampus alters normal synaptic transmission and plasticity, which could disturb learning and memory processing. Here we show, by electrophysiological recordings in CA1 of the hippocampal formation of rats, that hippocampal NPY gene transfer into the intact brain does not affect basal synaptic transmission, but slightly alters short-term synaptic plasticity, most likely via NPY Y2 receptor-mediated mechanisms. In addition, transgene NPY seems to be released during high frequency neuronal activity, leading to decreased glutamate release in excitatory synapses. Importantly, memory consolidation appears to be affected by the treatment. We found that long-term potentiation (LTP) in the CA1 area is partially impaired and animals have a slower rate of hippocampal-based spatial discrimination learning. These data provide the first evidence that rAAV-based gene therapy using NPY exerts relative limited effect on synaptic plasticity and learning in the hippocampus, and therefore this approach could be considered as a viable alternative for epilepsy treatment. (c) 2008 Wiley-Liss, Inc.
|
|